Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

Chimeric Antigen Receptor T (CAR-T) cell therapy significantly and rapidly changed the treatment paradigm for lymphoma, myeloma and leukemia, and the recent approvals of the first cellular immunotherapies in melanoma and synovial sarcoma demonstrate the potential success of this approach in solid tu...

Full description

Saved in:
Bibliographic Details
Main Authors: Tyler Ruemmele, Rodney Macedo, Mark N. Stein, Hei Ton Chan, Markus Y. Mapara, Céline F. Jacquemont, Ran Reshef
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1543622/full
Tags: Add Tag
No Tags, Be the first to tag this record!